Paragon 28, Inc. (NYSE:FNA) Stock Position Lifted by Barclays PLC

Barclays PLC increased its holdings in Paragon 28, Inc. (NYSE:FNA) by 180.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 84,812 shares of the company’s stock after buying an additional 54,591 shares during the period. Barclays PLC owned about 0.10% of Paragon 28 worth $567,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of FNA. Intech Investment Management LLC bought a new position in shares of Paragon 28 in the third quarter worth $70,000. Ballentine Partners LLC acquired a new stake in Paragon 28 during the 3rd quarter worth about $91,000. Creative Planning purchased a new stake in shares of Paragon 28 in the third quarter valued at $91,000. Hsbc Holdings PLC purchased a new stake in Paragon 28 in the 2nd quarter worth about $104,000. Finally, Commerce Bank boosted its holdings in shares of Paragon 28 by 28.5% during the third quarter. Commerce Bank now owns 18,350 shares of the company’s stock worth $123,000 after purchasing an additional 4,075 shares during the period. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 147,581 shares of the stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $10.28, for a total transaction of $1,517,132.68. Following the transaction, the insider now directly owns 10,738,564 shares in the company, valued at approximately $110,392,437.92. This represents a 1.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders sold 252,914 shares of company stock worth $2,585,514. Insiders own 15.32% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on FNA. Canaccord Genuity Group lowered their price target on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Needham & Company LLC restated a “buy” rating and set a $13.00 price objective on shares of Paragon 28 in a research report on Monday. Finally, Stephens raised Paragon 28 to a “strong-buy” rating in a report on Monday, December 2nd. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $15.60.

Paragon 28 Stock Up 3.4 %

Shares of Paragon 28 stock opened at $10.60 on Friday. The business’s 50 day simple moving average is $10.11 and its 200 day simple moving average is $8.08. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. Paragon 28, Inc. has a 52-week low of $4.65 and a 52-week high of $14.79. The firm has a market cap of $887.18 million, a PE ratio of -14.32 and a beta of 1.50.

Paragon 28 (NYSE:FNA) last announced its earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.01. The business had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. Paragon 28’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.10) EPS. On average, analysts predict that Paragon 28, Inc. will post -0.66 earnings per share for the current fiscal year.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.